13 results on '"Massuti, Bartomeu"'
Search Results
2. Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications
3. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
4. BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations
5. Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer
6. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
7. 14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
8. Effect of the Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients with Cisplatin/Gemcitabine-Treated Stage IV Non-Small-Cell Lung Cancer
9. A Phase II Study of Sequential Docetaxel Followed by Doxorubicin/Cyclophosphamide as First-Line Chemotherapy For Metastatic Breast Cancer
10. Pilot study of weekly-paclitaxel (P) and carboplatin (Cp) as 2-nd line chemotherapy (CT) in advanced pretreated non-small-cell-lung cancer (NSCLC)
11. Phase I study of the combination of oxaliplatin, irinotecan and 5-FU in patients with advanced solid tumours (TTD Spanish Cooperative Group)
12. Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy
13. Biweekly oxaliplatin (OXA) plus weekly 48h continuous infusion (CI) of 5FU (TTD regimen) for the first line treatment of advanced colorectal cancer (ACC). (TTD Spanish Cooperative Group).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.